Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates

Go back to Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
(NYSE: MANE) Delayed: 96.07 +1.67 (1.77%)
Previous Close $94.40    52 Week High
Open $94.37    52 Week Low
Day High $98.93    P/E N/A 
Day Low $92.11    EPS
Volume 260,390